RxDoctor Payments Data

Leopoldo Covarrubias

Child & Adolescent Psychiatry · Battle Creek, MINPI 1295916575

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.8% of the total across 119 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by Lundbeck LLC at 27.2% of the total. Reporting peaked in 2019 at $627 and has fallen 55.4% since, to $279 in 2021.

$1,509in general payments, 2019–2025

Across 119 payments — averaging $12.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lundbeck LLC$411
  • AbbVie$361
  • Otsuka America Pharmaceutical, Inc.$167
  • Takeda Pharmaceuticals U.S.A., Inc.$120
  • Sunovion Pharmaceuticals Inc.$95
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$71
  • plus $284 from 12 others

What the payments were for

  • Food & beverage$1,507100%
  • Education$20%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,509 in reported general payments places this provider in the 80th percentile of 73 child & adolescent psychiatry providers in Michigan.

See all child & adolescent psychiatry providers in Michigan

Other child & adolescent psychiatry in Battle Creek

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →